REMOVED: Phase II Trial of Allogeneic Hematopoietic Cell Transplantation for Mature NK/T Cell Neoplasms – Potent Graft Vs Tumor Effect Affords Remission Even with Refractory Disease
This abstract has been removed: please see Elsevier policy on article withdrawal (https://www.elsevier.com/about/policies-and-standards/article-withdrawal). This article has been removed at the request of the author. This abstract has been removed because it was not presented at the 2025 BMT Tandem Meeting.
Authors
- Anita Stokes
- Jennifer Sponaugle
- Christi McKeown
- Amy Chai
- Mustafa Hyder (ORCID: https://orcid.org/0000-0002-2452-1543)
- Scott Napier
- Jennifer A. Kanakry (ORCID: https://orcid.org/0000-0001-9522-3618)
- Dimana Dimitrova (ORCID: https://orcid.org/0000-0002-4868-6852)
- Syed Muhammad Salman Shah
- Christopher George Kanakry (ORCID: https://orcid.org/0000-0002-7736-2056)
- Jessenia Campos
- Jennifer Wilder
- Kamil Rechache
- Andrea Peluso (ORCID: https://orcid.org/0000-0002-6140-9825)
- Thomas E. Hughes
- Kristen Cole
- Ruby Sabina
Institutions
- National Institutes of Health (US)
- National Cancer Institute (US)
- Center for Cancer Research (US)
- National Institutes of Health Clinical Center (US)
Publication Details
- Journal
- Transplantation and Cellular Therapy
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1016/j.jtct.2025.01.049
- Primary Topic
- Immune Cell Function and Interaction
- Type
- article
- Field-Weighted Citation Impact
- 0.00